On November 4, 2025 Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, reported that members of management will present at two upcoming investor conferences.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies London Healthcare Conference
Fireside Chat on Monday, November 17, 2025 at 3:00pm GMT
Piper Sandler 37th Annual Healthcare Conference
Fireside Chat on Wednesday, December 3, 2025 at 2:00pm ET
The presentations will premiere at the time listed above and can be accessible by visiting the Presentation & Events section on the "Investors" page of Aligos’ website at www.aligos.com. A replay of the webcast will be available following the presentation for at least 30 days.
(Press release, Aligos Therapeutics, NOV 4, 2025, View Source [SID1234659342])